UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The good and bad of therapeutic strategies that directly target α‐synuclein

IUBMB life, 2020-04, Vol.72 (4), p.590-600

2020

Volltextzugriff (PDF)

Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts

Movement disorders, 2012-01, Vol.27 (1), p.8-30

Jellinger, Kurt A.

2012

Volltextzugriff (PDF)

Targeting α‐synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease

British journal of pharmacology, 2022-01, Vol.179 (1), p.23-45

2022

Volltextzugriff (PDF)

Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models

The Journal of neuroscience, 2014-07, Vol.34 (28), p.9441-9454

2014

Volltextzugriff (PDF)

Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease

Movement disorders, 2014-09, Vol.29 (10), p.1244-1251

2014

Volltextzugriff (PDF)

N‐terminal acetylation of α‐synuclein induces increased transient helical propensity and decreased aggregation rates in the intrinsically disordered monomer

Protein science, 2012-07, Vol.21 (7), p.911-917

2012

Volltextzugriff (PDF)

α-Synuclein Aggregation Intermediates form Fibril Polymorphs with Distinct Prion-like Properties

Journal of molecular biology, 2022-10, Vol.434 (19), p.167761-167761, Article 167761

2022

Volltextzugriff (PDF)

Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases

Progress in neurobiology, 2022-07, Vol.214, p.102270-102270, Article 102270

2022

Volltextzugriff (PDF)

Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease

Neurobiology of disease, 2021-01, Vol.148, p.105218-105218, Article 105218

2021

Volltextzugriff (PDF)

Mitochondrial dysfunction in Parkinson's disease

Journal of neurochemistry, 2016-10, Vol.139 (S1), p.216-231

2016

Volltextzugriff (PDF)

Randomized phase I clinical trial of anti–α‐synuclein antibody BIIB054

Movement disorders, 2019-08, Vol.34 (8), p.1154-1163

2019

Volltextzugriff (PDF)

Discontinuous Galerkin methods for Fisher–Kolmogorov equation with application to α-synuclein spreading in Parkinson’s disease

Computer methods in applied mechanics and engineering, 2023-12, Vol.417, p.116450, Article 116450

2023

Volltextzugriff (PDF)

A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of α-synuclein oligomers and phosphorylated α-synuclein aggregates

Brain, behavior, and immunity, 2024-10, Vol.121, p.122-141

2024

Volltextzugriff (PDF)

Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease

Movement disorders, 2021-01, Vol.36 (1), p.16-24

2021

Volltextzugriff (PDF)

The role of the C-terminus of human α-synuclein: Intra-disulfide bonds between the C-terminus and other regions stabilize non-fibrillar monomeric isomers

FEBS letters, 2011-02, Vol.585 (3), p.561-566

2011

Volltextzugriff (PDF)

Pathological substrate of memory impairment in multiple system atrophy

Neuropathology and applied neurobiology, 2022-12, Vol.48 (7), p.e12844-n/a

2022

Volltextzugriff (PDF)

Anti-amyloidogenic effect of artemin on α-synuclein

Biological chemistry, 2020

2020

Volltextzugriff (PDF)

Astrocyte-neuron communication through the complement C3-C3aR pathway in Parkinson’s disease

Brain, behavior, and immunity, 2025-01, Vol.123, p.229-243

2025

Volltextzugriff (PDF)

Tunneling nanotubes spread fibrillar α-synuclein by intercellular trafficking of lysosomes

The EMBO journal, 2016-10, Vol.35 (19), p.2120-2138

2016

Volltextzugriff (PDF)

Direct evidence for ultrastructures of the α-synuclein-associated synaptic vesicle pool in presynaptic terminals

Biochimica et biophysica acta. Molecular basis of disease, 2024-12, Vol.1870 (8), p.167494, Article 167494

2024

Volltextzugriff (PDF)

Complement and Coagulation Cascades are Potentially Involved in Dopaminergic Neurodegeneration in α‑Synuclein-Based Mouse Models of Parkinson’s Disease

Journal of proteome research, 2021-07, Vol.20 (7), p.3428-3443

2021

Volltextzugriff (PDF)

Comparative study of cerebrospinal fluid α‐synuclein seeding aggregation assays for diagnosis of Parkinson's disease

Movement disorders, 2019-04, Vol.34 (4), p.536-544

2019

Volltextzugriff (PDF)

The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease

Free radical biology & medicine, 2019-05, Vol.135, p.28-37

2019

Volltextzugriff (PDF)

Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic

Movement disorders, 2018-05, Vol.33 (5), p.684-696

2018

Volltextzugriff (PDF)

Structural Insights of Fe3+ Induced α-synuclein Fibrillation in Parkinson’s Disease

Journal of molecular biology, 2023-01, Vol.435 (1), p.167680, Article 167680

2023

Volltextzugriff (PDF)

1 – 25 von 5.304

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(5.037)
Mit Volltextzugriff
(4.819)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Α-Synuclein
(4.755)
Science & Technology
(4.497)
Life Sciences & Biomedicine
(4.273)
Parkinson's Disease
(2.939)
Humans
(2.740)
Neurosciences & Neurology
(2.487)
Neurosciences
(2.238)
Alpha-Synuclein - Metabolism
(1.814)
Animals
(1.712)
Biochemistry & Molecular Biology
(1.327)
Parkinson’s Disease
(1.209)
Synuclein
(1.162)
Neurodegenerative Diseases
(1.078)
Movement Disorders
(918)
Parkinson Disease - Metabolism
(906)
Neurology
(868)
Neurodegeneration
(866)
Clinical Neurology
(850)
Proteins
(850)
Male
(828)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(3.513)
Ingenta
(2.967)
EZB Electronic Journals Library
(2.436)
Journals@Ovid Complete
(1.717)
Elsevier ScienceDirect Journals Complete
(1.424)
IngentaConnect Journals
(1.413)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(1.106)
Wiley-Blackwell Journals
(878)
SpringerLink_现刊
(844)
Wiley Online Library
(773)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(532)
NUS Single-Journal Subscriptions
(322)
Taylor & Francis Journals
(206)
Nexis Uni
(154)
Taylor & Francis
(154)
Oxford University Press Journals Current
(133)
Oxford Journals 2020 Medicine
(121)
Taylor & Francis Online
(114)
Ebook Central Perpetual and DDA
(113)
eBooks on EBSCOhost
(113)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The good and bad of therapeutic strategies that directly target α‐synuclein

Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts

Targeting α‐synuclein aggregation and its role in mitochondrial dysfunction in Parkinson's disease

Reducing C-terminal-truncated alpha-synuclein by immunotherapy attenuates neurodegeneration and propagation in Parkinson's disease-like models

Stage-dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease

N‐terminal acetylation of α‐synuclein induces increased transient helical propensity and decreased aggregation rates in the intrinsically disordered monomer

α-Synuclein Aggregation Intermediates form Fibril Polymorphs with Distinct Prion-like Properties

Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases

Exosome-mediated delivery of antisense oligonucleotides targeting α-synuclein ameliorates the pathology in a mouse model of Parkinson's disease

Mitochondrial dysfunction in Parkinson's disease

Randomized phase I clinical trial of anti–α‐synuclein antibody BIIB054

Discontinuous Galerkin methods for Fisher–Kolmogorov equation with application to α-synuclein spreading in Parkinson’s disease

A rapidly progressive multiple system atrophy-cerebellar variant model presenting marked glial reactions with inflammation and spreading of α-synuclein oligomers and phosphorylated α-synuclein aggregates

Ten Unsolved Questions About Neuroinflammation in Parkinson's Disease

The role of the C-terminus of human α-synuclein: Intra-disulfide bonds between the C-terminus and other regions stabilize non-fibrillar monomeric isomers

Pathological substrate of memory impairment in multiple system atrophy

Anti-amyloidogenic effect of artemin on α-synuclein

Astrocyte-neuron communication through the complement C3-C3aR pathway in Parkinson’s disease

Tunneling nanotubes spread fibrillar α-synuclein by intercellular trafficking of lysosomes

Direct evidence for ultrastructures of the α-synuclein-associated synaptic vesicle pool in presynaptic terminals

Complement and Coagulation Cascades are Potentially Involved in Dopaminergic Neurodegeneration in α‑Synuclein-Based Mouse Models of Parkinson’s Disease

Comparative study of cerebrospinal fluid α‐synuclein seeding aggregation assays for diagnosis of Parkinson's disease

The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease

Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic

Structural Insights of Fe3+ Induced α-synuclein Fibrillation in Parkinson’s Disease

Suchergebnisse filtern